Rising fish prices coexist with the difficulty of reproducing fry. Improving the survival rate of fry has become the key to improving pond efficiency, and reasonable disinfection and prevention planning is an important means to ensure the survival rate of fry.
Because beef cattle eat roughage, pasture, etc. and often come into contact with the ground, they are easily infected with various nematodes in the digestive tract, and are also susceptible to parasites such as lice, mites, ticks, and fly maggots outside the body. After a cow's body is mildly to moderately infected with parasites, the feed conversion rate is affected, mainly due to a decrease in appetite, a decrease in absorbed protein and energy utilization, and a decrease in the quality and weight gain of ketone bodies, which in turn affects the efficiency of beef cattle breeding. Economic benefits. For this reason, beef cattle must be dewormed during the pre-feeding period before fattening.
With the improvement of the breeding model and the improvement of feeding and management technology, it seems that the frequency of bursitis has decreased in recent years, resulting in people not paying much attention to preventing and controlling this disease during breeding and production. In fact, the incidence of bursitis in chickens has always been high.
The reduction in pig production capacity in the fourth quarter will be realized in the reduction of pig supply after the third quarter of 2024, when pig prices may recover.
Due to the improvement of global production capacity, chicken production has generally shown a steady growth trend, but there was also a decline in global chicken production in 2016. In 2012, the total global chicken production was 84.91 million tons, and by 2023 it is expected to be 103.52 million tons, with an average annual compound growth rate of 1.66%. In recent years, the growth of global chicken production has slowed down. Since the year-on-year growth rate reached a peak of 5.03% in 2019, the growth rate has shown a downward trend, with the year-on-year growth rate in 2022 being only 0.85%.
With the rapid rise in the emergence of bacterial strains resistant to multiple classes of antimicrobial agents, there is an urgent need to develop novel antimicrobial therapies to combat these pathogens.